Related Experiment Videos
Paediatric care of the child with haemophilia
1Department of Paediatric and Coagulation Disorders, Lund University, University Hospital, Sweden. rolf.ljung@paediatrik.mas.lu.se
Insights
Paediatric haemophilia care should prioritize the child's overall health. Empowering patients with self-managed prophylaxis and utilizing new assessment tools can improve quality of life while awaiting gene therapy advancements.
Area of Science:
- Pediatric Hematology
- Hemophilia Management
- Gene Therapy Research
Background:
- Current pediatric hemophilia care in developed nations often centers on the disorder itself.
- While gene therapy presents a potential cure, it is not yet a widely available treatment option.
Purpose of the Study:
- To advocate for a shift in pediatric hemophilia care towards the child's holistic health.
- To highlight the importance of patient empowerment in treatment management.
- To emphasize the role of new assessment tools in enhancing care.
Main Methods:
- Review of current pediatric hemophilia care paradigms.
- Discussion of emerging treatment strategies, including self-monitored prophylaxis.
- Emphasis on the utility of novel instruments for assessing joint function, radiographic changes, and quality of life.
Main Results:
- A child-centered approach to hemophilia care is recommended.
- Self-monitored and self-adjusted prophylaxis empowers patients and improves treatment adherence.
- Advanced measurement tools provide objective data for better treatment evaluation and adjustment.
Conclusions:
- Pediatric hemophilia care should focus on the child's overall well-being, not solely on the condition.
- Patient-centered management, including self-care strategies, is crucial.
- Technological advancements in assessment are vital for optimizing hemophilia treatment and improving patient outcomes.
Abstract:
The paediatric care of children with haemophilia in developed countries should focus on the health of the child, not on the disorder. Gene therapy offers the hope of an ultimate 'cure' for the disorder, but until this is a viable proposition, patients should be given more control over their treatment, and the focus should be on 'self-monitored and self-adjusted' prophylaxis. New instruments for measuring joint function and radiographic changes, and quality of life are valuable tools in improving the treatment of paediatric care for children with haemophilia.